During the 2019 International Production & Processing Expo, Phibro Animal Health introduced its new Provia Prime direct-fed microbial product, which helps optimize the gut microbiome for improved health, immunity and productivity in poultry.
“A healthy microbiome can result in increased bodyweight and improved feed conversion,” explained Paulo Rezende-Napier, Phibro product director. “Having a healthy microbiome may also lead to lower mortality rates and reduced lesions from pathogens such as Clostridium perfringens, Escherichia coli and salmonella in commercial poultry production.”
According to Phibro, Provia Prime is in a class of Bacillus-based direct-fed microbials that have been shown to promote beneficial gut bacteria, which can help improve immunity, foster gut health and act as natural growth promoters. The new product includes a patent-pending proprietary combination of four powerful probiotic strains of Bacillus subtilis, Bacillus licheniformis, Bacillus coagulans and Bacillus amyloliquefaciens. Together these four strains create a synergistic effect that encourage a higher population in the gut of “good bacteria,” which can help support broiler health and increase yield, the company said.
The microbial strains in Provia Prime offer superb heat stability, a long shelf life, have no refrigeration requirements and have high viability in the gut with a high survivability rate against gastric acid and bile salts.
“As consumer, regulatory and financial pressures on both poultry integrators and growers make business success more challenging than ever, Provia Prime holds great promise for poultry producers,” Rezende-Napier said. “Healthier birds, which are better able to withstand the stress of pathogens, can help reduce costs of production, increase potential return on investment and help ensure plentiful and affordable protein for consumers.”